Primary Hyperparathyroidism
Primary hyperparathyroidism (PHPT) is defined as excessive parathyroid hormone (PTH) production resulting in hypercalcemia, typically caused by autonomous overproduction of PTH from one or more parathyroid glands. 1
Pathophysiology and Causes
Primary hyperparathyroidism occurs when the parathyroid glands autonomously overproduce parathyroid hormone, disrupting normal calcium homeostasis. The etiology includes:
- Single parathyroid adenoma (80%) - most common cause 1
- Multiple adenomas or multigland hyperplasia (15-20%) 1
- Parathyroid carcinoma (<1%) - rare cause 1
Some cases are hereditary, associated with:
- Multiple endocrine neoplasia types 1 and 2A
- Familial hyperparathyroidism
However, most cases are sporadic in nature 1.
Epidemiology
PHPT demonstrates significant demographic patterns:
- More common in women (incidence of 66 per 100,000 person-years)
- Less common in men (25 per 100,000 person-years)
- Prevalence increasing significantly in recent decades 1
- Most frequently found in the 6th to 7th decade of life 2
Clinical Presentation
The presentation varies significantly based on geographic location and screening practices:
In countries with routine biochemical screening (US, Canada, Europe):
- Predominantly asymptomatic - discovered incidentally through routine blood tests showing hypercalcemia 1
- Normocalcemic variant - characterized by elevated PTH with normal calcium values, still at risk for complications 1
In countries without routine screening (China, India):
- Symptomatic presentation with target organ involvement 1
Clinical Manifestations
PHPT affects multiple organ systems:
Skeletal manifestations:
Renal manifestations:
- Nephrolithiasis (kidney stones)
- Nephrocalcinosis
- Impaired kidney function 1
Neurocognitive manifestations:
Cardiovascular manifestations:
- Potential cardiovascular complications 2
Diagnosis
The diagnosis of PHPT is established through biochemical testing:
- Elevated or inappropriately normal PTH with hypercalcemia is the hallmark 1
- Hypercalcemia - key diagnostic finding
- Hypophosphatemia - often present
- Elevated alkaline phosphatase - indicates bone involvement
- Elevated 24-hour urine calcium - provides further confirmation 4
Important diagnostic considerations:
- Imaging has no role in confirming or excluding PHPT - diagnosis is biochemical 1
- Assay-specific reference values should be used for PTH measurement 1
- Normocalcemic PHPT is characterized by elevated PTH with normal calcium values 1, 5
Treatment
Surgical Management:
Parathyroidectomy is the only curative treatment for PHPT and is indicated for symptomatic patients and those with complications. 1, 2
Specific surgical indications include:
- Symptomatic disease
- Osteoporosis
- Impaired kidney function (GFR < 60 mL/min/1.73 m²)
- Kidney stones
- Hypercalciuria
- Age ≥ 50 years
- Calcium increased by more than 0.25 mmol/L above upper limit of normal 1
Surgical approaches:
- Bilateral neck exploration (BNE) - traditional approach examining all parathyroid glands
- Minimally invasive parathyroidectomy (MIP) - targeted removal of affected gland(s) 1
MIP requires:
- Confident preoperative localization of adenoma
- Intraoperative PTH monitoring 1
Medical Management:
For patients who are not surgical candidates, options include:
- Bisphosphonates
- Calcitonin
- Calcimimetics 2
Preoperative Imaging
Imaging is used to localize abnormal glands before surgery, not for diagnosis:
- CT neck without and with IV contrast (4-D parathyroid CT) - sensitivity 62-88%, PPV 84-90% 1
- Nuclear scanning with technetium-99-m sestamibi 4
- Radio-guided probes - used intraoperatively 4
Complications and Prognosis
If left untreated, PHPT can lead to:
- Progressive bone disease
- Renal complications
- Neurocognitive deterioration
- Potentially death in severe cases 6
Surgical cure rates are high with experienced surgeons, and complication rates are relatively low 6, 5.